机构:[a]Department of Neurobiology, Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing Institute of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China老年医学科首都医科大学宣武医院[b]Center for Cognition and Brain Disorders, Affiliated Hospital, Hangzhou Normal University, China[c]Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Background: The pathophysiological changes before the presentation of clinical symptoms in parkinsonism are unclear. In this study, we investigated neural network modulations in persons in the preclinical stage of familial parkinsonism, and how the network interactions change at the clinical stage. Methods: We performed functional MRI in a family with SCA2 mutation, including 9 asymptomatic carriers and 10 mutation carriers with parkinsonian symptoms. Functional connectivity from the posterior putamen bilaterally and rostral supplementary motor area was used to explore network interactions in the subjects. Results: Both the asymptomatic carriers and patients had decreased connectivity within the basal ganglia-thalamus-cortical motor loop compared to controls. The asymptomatic carriers showed extensively increased connectivity compared to controls, including the cortico-cortical motor, cortico-cerebellar, cortico-brainstem, and part of the basal ganglia-thalamus-cortical motor circuits. In contrast, the connectivity of most of these networks was decreased in the patients. These abnormalities were relatively normalized after levodopa administration. Conclusions: In the preclinical stage of SCA2 parkinsonism, the connectivity of a part of the basal ganglia motor loop is weakened as a consequence of dopaminergic deficits; meanwhile, the connectivity of other large-scale brain networks is strengthened presumably to compensate for the dysfunction of the basal ganglia to maintain brain function in the early stage of dopaminergic deficits. The simultaneous effects of progressive disruption of basal ganglia motor circuits and failure of compensatory mechanisms as dopaminergic dysfunction progresses may contribute to the onset of clinical symptoms. (C) 2012 Elsevier Ltd. All rights reserved.
基金:
National Science Foundation of China (30570530, 30870693, and 81071012)
第一作者机构:[a]Department of Neurobiology, Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing Institute of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
通讯作者:
通讯机构:[a]Department of Neurobiology, Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing Institute of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
Tao Wu,Chaodong Wang,Jue Wang,et al.Preclinical and clinical neural network changes in SCA2 parkinsonism[J].PARKINSONISM & RELATED DISORDERS.2013,19(2):158-164.doi:10.1016/j.parkreldis.2012.08.011.
APA:
Tao Wu,Chaodong Wang,Jue Wang,Mark Hallett,Yufeng Zang&Piu Chan.(2013).Preclinical and clinical neural network changes in SCA2 parkinsonism.PARKINSONISM & RELATED DISORDERS,19,(2)
MLA:
Tao Wu,et al."Preclinical and clinical neural network changes in SCA2 parkinsonism".PARKINSONISM & RELATED DISORDERS 19..2(2013):158-164